Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimize First-line Treatment for Systemic Light Chain Amyloidosis With t (11; 14)

NCT06192979 is registered in ClinicalTrials.gov with Jin Lu, MD as lead sponsor.

NCT NCT06192979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimize First-line Treatment for Systemic Light Chain Amyloidosis With t (11; 14)
Lead sponsor
Jin Lu, MD
Phase
Not applicable
Overall status
Recruiting
Start date
January 5, 2024
Completion date
March 31, 2027
Enrollment
41 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis, amyloidosis; systemic